Pfizer Financial Summary
PFIZER
History
Pfizer is a research-based pharmaceutical company founded by two cousins called Charles Pfizer and Charles Erhard. It was founded in 1849 in New York City (NYC), USA. It is the largest Pharmaceutical Company in the whole world. They are listed on the New York Stock Exchange (NYSE) as PFE. Its number of shares of common stock is outstanding and it is about 6,128,855,392. Their portfolio includes medicines and other well-known healthcare products. They manufacture products in five main areas which are; specialty care and oncology, animal health, primary care, nutrition and customer healthcare. They produce medicines and vaccines for diabetology, cardiology, neurology, immunology etc. Some of their drugs include diflucan (oral
…show more content…
2013 2014 Equity Share 29.8 29.8 29841440 10.0 29.8
2012 2013 Equity Share 29.8 29.8 29844080 10.0 29.8
2011 2012 Equity Share 29.8 29.8 29841440 10.0 29.8
2009 2011 Equity Share 29.8 29.8 29841440 10.0 29.8
2008 2009 Equity Share 29.8 29.8 29841440 10.0 29.8
2007 2008 Equity Share 29.8 29.8 29841440 10.0 29.8
2006 2007 Equity Share 29.8 29.8 29841440 10.0 29.8
2005 2006 Equity Share 29.8 29.8 29841440 10.0 29.8
2004 2005 Equity Share 29.8 29.8 29841440 10.0 29.8
2003 2004 Equity Share 28.8 28.8 28797540 10.0 28.8
2002 2003 Equity Share 28.8 28.8 28797540 10.0 28.8
2001 2002 Equity Share 23.4 23.4 23440296 10.0 23.4
2000 2001 Equity Share 23.4 23.4 23440296 10.0 23.4
1999 2000 Equity Share 23.4 23.4 23440296 10.0 23.4
1998 1999 Equity Share 11.7 11.7 11720148 10.0 11.7
1981 1999 Equity Share 11.7 11.7 11720148 10.0 11.7
1994 1998 Equity Share 11.7 11.7 11720148 10.0 11.7
1977 1981 Equity Share 10.0 10.0 10045848 10.0 10.0
1972 1977 Equity Share 5.6 5.6 5581028 10.0 5.6
1970 1972 Equity Share 4.0 4.0 3986420 10.0 4.0
1968 1970 Equity Share 4.0 4.0 3987480 10.0 4.0
1967 1968 Equity Share 2.7 2.7 2198000 10.0 2.2
1966 1967 Equity Share 2.7 2.7 2198000 10.0 2.2
1965 1966 Equity Share 2.0 2.0 2000000 10.0 2.0
1964 1965 Equity Share .8 .8 750000 10.0
…show more content…
http://www.4-traders.com/PFIZER-INC-4821/company/
6. Joseph, G (2000). A Brief History of Pfizer Central Research. Retrieved from http://www.scs.illinois.edu/~mainzv/HIST/bulletin_open_access/v25-1/v25-1%20p10-15.pdf
7. Investopedia, corporate finance. Retrieved from; http://www.investopedia.com/terms/c/corporategovernance.asp
8. Pfizer, OUR IMPACT ANNUAL REVIEW 2010, Stakeholder Engagement. Retrieved from; http://www.pfizer.com/files/annualreport/2010/review2010_stakeholderengage.pdf
9. Newsblog, Say what? Pfizer calls PLoS out on conflict of interest. Retrieved from; http://blogs.nature.com/news/2010/09/say_what_pfizer_calls_plos_out.html
10. Katharina, W (2011) From Codes of Conduct to Ethics and Compliance Programs: Recent Developments. P.81. Retrieved from; https://books.google.com.gh/books?id=ziqqXyLVHskC&pg=PA81&lpg=PA81&dq=is+there+any+conflict+of+interest+in+Pfizer&source=bl&ots=DnCGj-03Ge&sig=1ZTzjzFCEjQby3ADnZ4w1Y9jTiQ&hl=en&sa=X&ei=D5cFVb6wKcLcaqaPgKgC&ved=0CDEQ6AEwBA#v=onepage&q=is%20there%20any%20conflict%20of%20interest%20in%20Pfizer&f=false
11. Capital structure, Investopedia. Retrieved from; http://www.investopedia.com/terms/c/capitalstructure.asp
12.
NAADC Code Of Ethics Analysis
449 Words | 2 PagesThe NAADC Code of Ethics are stipulations that dictate the attitudes and behaviors of people. The NAADC Code of Ethics provides guidance for individuals in the addictions behavioral health field to perform as honest and virtuous professionals. The codes suggest identifying your own strengths and weaknesses, skills, and areas that need improvement. The NAADC codes were established to direct the members. The regulations are the criteria of behavior for addiction experts.
Marketing Plan For Allround: OTC Cold Medicine
670 Words | 3 PagesPharmaSIM- Marketing Plan MKTG 613: MARKETING MANAGEMENT Professor Suresh Ramanathan TEAM GAMMA SEVEN Britton Eastburn Temitope Kayode-Ojo Brian Newbury Harsha Srinivasan Introduction: The ALLSTAR brand is one of the leading manufacturers of packaged goods in the world. The company was started in 1924 and it now consists of a consumer product, an international and a pharmaceutical division. The pharmaceutical division of the company produces and markets ethical and OTC medicine.
Jagdambay Exports Case Study
1681 Words | 7 PagesThe capital business sector is the business sector for securities, where organizations and the legislature can raise long haul stores. The capital business sector incorporates the stock exchange what 's more, the security market. Money related controllers, for example, the U.S. Securities and Exchange Commission, direct the capital markets in their individual nations to guarantee that financial specialists are ensured against extortion. The capital markets comprise of the essential business sector, where new issues are appropriate to financial specialists, and the optional business sector, where existing securities are exchanged. (n.d.).
Dollarama's Code Of Conduct And Ethics
1673 Words | 7 Pages• Conflicts of interest, including transactions and agreements within which a director, executive officer
Strengths And Weaknesses Of Pfizer
1170 Words | 5 PagesPfizer has a significant amount of cash on hand and investments held overseas. Changes to the US corporate tax system now means overseas cash is taxed at 15%. This means Pfizer can more easily access funds with less penalty. Human Resources Management. • Staff Recruitment • Training
Target Financial Summary
866 Words | 4 PagesTarget Corporation is the second largest discount store retailer in the United States following Walmart. Target provides high-quality, trendy merchandise at logical prices. As of today, Target has more than 1800 retail stores and 38 distribution centers in the United States. The first official store was opened in 1962 in Roseville Minnesota and have thrived every since. I will be analyzing Target’s financial statements and communicating the results to our decision makers (Target 2017).
Essay On Cialis
940 Words | 4 PagesProblem Identification: Cialis was trying to enter into the market which was already well established by its competitors. The revenues of Pfizer were sky touching and they already had a mechanism to sell Viagra at very bottom level. They invested lot of money for branding Viagra using celebrities in TV commercials. Pfizer also had huge sales teams going to doctors and convince them to prescribe Pfizer’s medication to the patients.
Moral Dilemma In Occupational Therapy
893 Words | 4 PagesMoral Dilemma HOSPITAL: You started your first job at a large hospital. You are assigned a patient to treat who no one wants to work with because the patient always says “NO”. The Occupational Therapy team leader tells you that you need to treat the patient because the doctor is angry that the patient has not been receiving therapy. You are told that the patient’s nurse has called to complain to the therapy department about the fact that the patient has not been receiving therapy
Health Care Stakeholders Analysis
1010 Words | 5 PagesFor example, a patient may need a specific treatment. The physician’s administration attempt to gain approval form the insurance company to proceed with the treatment and is denied. The insurance company instead gives the physician another less expensive option. Though the option presented is less likely to give a better percentage of a positive outcome for the patient. The physician has a clear conflict in pleasing both the insurance company and the patient.
Assess The Strengths And Weaknesses Of Merck
825 Words | 4 PagesThe goal is to make a lifechanging medication at an affordable price. Also, owning a lot of patents under their name has helped them earn a lot of profits. The Merck company has succeeded in differentiating itself as cost leadership
Porter's Five Forces In The Pharmacy Industry
1156 Words | 5 PagesThe number of acquisitions is not so high and it depends more upon the organic expansion. • These pharmacies face informative and predictable risk from the variability of “generic conversion” • Inability of the company to keep stride with the growing private labeled brands popularity. • The in-store implementation of the store formats and services is not consistent at every
My Reflection On Medication History
831 Words | 4 PagesMedication History Reflective Writing Pharmacy Practice II Shaymous Juhnke As a student in SDSU’s pharmacy program one of the activities required to prepare us for real world pharmacy practice is to perform a medication history. Performing a medication history and reviewing it can be helpful to in acquiring information about a patents disease states, keeping an up to date record on their current medications, and helps prevent and resolve potential and current issues with patents medications.
Porter's Five Forces Analysis Pharmaceutical Industry
720 Words | 3 PagesPORTERS FIVE FORCES ANALYSIS - PHARMA INDUSTRY Using Porter's Five Forces we can analyse the scope of the pharmaceutical industry. It looks into five factors namely, competitive rivalry, threat of new entrants, threat of substitute products, bargaining power of suppliers and bargaining power of customers. " Competitive rivalry: The pharmaceutical industry is highly fragmented with almost 3,000 pharma companies and 10,500 manufacturing units. Due to increasing demand of high-quality drugs, low-to-moderate entry barrier to the new entrant, the presence of a number of large and small firm this market is highly competitive.
Business Ethics Case Study: The Johnson And Johnson Case
1262 Words | 6 PagesIntroduction The key ethical issues that were presented in this case study were quality control, lack of customer care, responsiveness, and harming the customer. The Johnson and Johnson case may have been seen as a turning point due to many things the company did right. However, there were many ethical issues in this case which will be explored more throughout this paper.
Rorer Converts-Poulenc Case Study
2104 Words | 9 PagesINTRODUCTION The latter decade of the 20th century brought a number of major innovations to the pharmaceutical industry, most notably a remarkable wave of successful joint ventures and mergers between big and medium players in the market. In this case study we analyzed the Rorer and Rhône-Poulenc (RP) merger in July 31, 1990 that created a major multinational company: the Rhône-Poulenc Rorer, Inc. (RPR), where the RP became the majority shareholder, owning 68 percent of the RPR’s shares. Prior to the merger, Rorer lacked the resources to access the European market, and the firm presented relatively low cash balance and rising debt which, according to financial analysts, appeared to be handicapping its strategy of growth by acquisitions.
More about Pfizer Financial Summary
NAADC Code Of Ethics Analysis
449 Words | 2 PagesMarketing Plan For Allround: OTC Cold Medicine
670 Words | 3 PagesJagdambay Exports Case Study
1681 Words | 7 PagesDollarama's Code Of Conduct And Ethics
1673 Words | 7 PagesStrengths And Weaknesses Of Pfizer
1170 Words | 5 PagesTarget Financial Summary
866 Words | 4 PagesEssay On Cialis
940 Words | 4 PagesMoral Dilemma In Occupational Therapy
893 Words | 4 PagesHealth Care Stakeholders Analysis
1010 Words | 5 PagesAssess The Strengths And Weaknesses Of Merck
825 Words | 4 PagesPorter's Five Forces In The Pharmacy Industry
1156 Words | 5 PagesMy Reflection On Medication History
831 Words | 4 PagesPorter's Five Forces Analysis Pharmaceutical Industry
720 Words | 3 PagesBusiness Ethics Case Study: The Johnson And Johnson Case
1262 Words | 6 PagesRorer Converts-Poulenc Case Study
2104 Words | 9 Pages